+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Laser Capture Microdissection Market - Growth, Trends, and Forecast (2020 - 2025)

  • PDF Icon

    Report

  • 112 Pages
  • August 2020
  • Region: Global
  • Mordor Intelligence
  • ID: 4622387
UP TO OFF until Mar 31st 2024
The market studied is being driven by factors, such as an increase in the R&D funding, along with the increasing healthcare expenditure and technological advancements in the Laser Capture Microdissection (LCM).

According to the Office for National Statistics (ONS), the total R&D expenditure in the United Kingdom is increasing rapidly. During 2016, it was around GBP 33.2 billion, which increased in 2017 and reached around GBP 34.8 billion. Similarly, in the United States, the investments in medical R&D was USD 39.5 billion in 2017. This indicates that there is a high investment done in healthcare in the major countries.

Trends are showing a return to growth, with only minor caution, across most areas of R&D spending. The increase in R&D investment in Asia, particularly India, and the consecutive annual growth in R&D spending in the country, indicate a period of stability, security, and healthy competition across the industrial sectors. A national survey by the Central Government of India, on the status of R&D in the country, has shown that India’s Gross Expenditure on R&D (GERD) has more than tripled, from INR 241.17 billion (INR 24,117 crore) to INR 853.26 billion (INR 85,326 crore) during the decade, from 2004-2005 to 2014-2015.

Furthermore, it is indicated that the rising R&D investment will have a positive impact on the market studied and the market will grow rapidly over the forecast period.

Key Market Trends

Diagnostics is Expected to Register a Highest CAGR Over the Forecast Period

Currently, microdissection of tissue sections and cytological preparations have been used increasingly for the isolation of homogeneous, morphologically identified cell populations, thus, overcoming the obstacle of tissue complexity. In conjunction with sensitive analytical techniques, such as the polymerase chain reaction, microdissection allows precise in vivo examination of cell populations, such as carcinoma in situ, or the malignant cells of Hodgkin's disease, which are otherwise inaccessible for conventional molecular studies.

Laser Capture Microdissection (LCM) may allow the establishment of "genetic fingerprints" of specific pathological lesions, especially malignant neoplasms. In addition to the identification of new diagnostic and prognostic markers, this approach could help in establishing individualized treatment, tailored to the molecular profile of a tumor. Thus, the increased application of LCM in diagnostics is augmenting the growth of the market.

North America to Dominate the Market

Geographically, North America is dominating the global laser capture micro-dissection market, primairly due to the availability of skilled personnel. Also, due to robust healthcare infrastructure in the United States, which is coupled with extensive funding for medical research projects. This will continue to fuel the adoption of laser capture micro-dissection in North America. It has been observed that Asia-Pacific will be the fastest-growing market for laser capture microdissection, mainly due to the rising investment in healthcare R&D in Asian countries.

Competitive Landscape

The laser capture microdissection market is moderately competitive and consists of the global, as well as local players. In countries, like India, there are several local players and these companies are holding a substantial share of the market. A similar scenario was observed in developed countries, such as the United States and a few European countries. With the rising focus on R&D, it is believed that more companies will enter the market in the coming future.

Reasons to Purchase this report:
  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increase in R&D Funding and Healthcare Expenditure
4.2.2 Technical Advantages of LCM
4.3 Market Restraints
4.3.1 High Cost of Instruments, Accessories, and Maintenance
4.3.2 Lack of Skilled Professionals
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Product
5.1.1 Instruments
5.1.2 Consumables
5.1.3 Software and Services
5.2 By System Type
5.2.1 Ultravoilet LCM
5.2.2 Infrared LCM
5.2.3 Other System Types
5.3 By Application
5.3.1 R&D
5.3.2 Diagnostics
5.3.3 Other Applications
5.4 By End-User
5.4.1 Academic and Government Research Institutes
5.4.2 Hospitals
5.4.3 Pharmaceutical, Biotechnology Companies, and CROs
5.5 Geography
5.5.1 North America
5.5.1.1 United States
5.5.1.2 Canada
5.5.1.3 Mexico
5.5.2 Europe
5.5.2.1 Germany
5.5.2.2 United Kingdom
5.5.2.3 France
5.5.2.4 Italy
5.5.2.5 Spain
5.5.2.6 Rest of Europe
5.5.3 Asia-Pacific
5.5.3.1 China
5.5.3.2 Japan
5.5.3.3 India
5.5.3.4 Australia
5.5.3.5 South Korea
5.5.3.6 Rest of Asia-Pacific
5.5.4 Middle-East and Africa
5.5.4.1 GCC
5.5.4.2 South Africa
5.5.4.3 Rest of Middle-East and Africa
5.5.5 South America
5.5.5.1 Brazil
5.5.5.2 Argentina
5.5.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Carl Zeiss Meditec AG
6.1.2 Thermo Fisher Scientific
6.1.3 Danaher Corporation (Leica Microsystems)
6.1.4 Molecular Machines & Industries GmbH
6.1.5 Fluidgm Corporation
6.1.6 Caresbio Laboratory LLC
6.1.7 VitroVivo Biotech
6.1.8 GnomeDX
7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Carl Zeiss Meditec AG
  • Thermo Fisher Scientific
  • Danaher Corporation (Leica Microsystems)
  • Molecular Machines & Industries GmbH
  • Fluidgm Corporation
  • Caresbio Laboratory LLC
  • VitroVivo Biotech
  • GnomeDX

Methodology

Loading
LOADING...